Living with cancer: using patient perspective to accelerate oncology care

  • Overall survival in RCC is improving significantly, but with this comes new considerations – for example, what should living with cancer look like, and how can we best support patients in the long term?
  • Quality of life-specific endpoints must be standard in future clinical trial protocols
  • Patient reported outcomes (PROs) are not regularly collected or recorded as part of routine clinical practice, despite evidence suggesting clinical benefits
  • Through long-term data collation, with an increased focus on real world-data (RWD) and contribution to registries, we can develop a holistic view across cancer treatments for patient


Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: FEB2020BR001